Penn State Health Milton S. Hershey Medical Center is one of eight academic medical centers nationwide taking part in a clinical trial of Cxbladder — a noninvasive test that could spare thousands of patients the pain and expense involved in evaluating a diagnosis of hematuria.
Patients with a noninvasive, low-grade form of bladder cancer often need multiple surgeries to treat recurrences, which are common. A new chemoablative gel currently under study at Penn State Health may eliminate the need for those procedures.
Expanded Clinical Trials at Penn State Cancer Institute Boost Area Patients’ Access to Leading-Edge Care
With a significant expansion of researcher-driven clinical trials and a sharp focus on the region’s distinct healthcare needs, Penn State Cancer Institute (PSCI) is bringing the latest in cancer treatments to central Pennsylvania.
Neurosurgery at Penn State Health Milton S. Hershey Medical Center: Innovative Procedures, Lifelong Benefits
Penn State Health Milton S. Hershey Medical Center providers leverage proven technology, high-level training and rigorous scientific inquiry to treat a broad spectrum of intractable neurological conditions, while laying the foundation for treatments that may help even larger patient populations.
From advanced pediatric medical and surgical care to in-house research and collaborative clinical investigation with national pediatric leaders, the scientists, providers and care teams at Penn State Children’s Hospital continue to break down barriers to inform treatment and foster excellent outcomes for children and families throughout Pennsylvania and the surrounding region.
Penn State Health Milton S. Hershey Medical Center: High-level Care and Research with a Regional Focus
A rigorous emphasis on primary and specialty care, research, and education sets Penn State Health Milton S. Hershey Medical Center apart in regional healthcare delivery.
At Penn State Health Milton S. Hershey Medical Center, physician-scientists provide advanced treatments for acute and chronic heart conditions, while furthering the Heart and Vascular Institute’s mission to develop and perfect lifesaving therapies and technologies.
ESTABLISHED IN 2000, Penn State Cancer Institute, recognized as an American College of Surgeons Commission on Cancer-accredited facility, has evolved into a premier academic oncology center that encompasses clinical care, research, education and outreach. Since 2009, the 178,000-square-foot facility on the Milton S. Hershey Medical Center campus has served as the hub for nearly 160 clinicians, researchers and faculty members based in Hershey and University Park, State College in Centre County. The Cancer Institute care teams see nearly 2,000 individual cases annually.
In May of 2013, PinnacleHealth embarked on an exciting journey in caring for patients with blocked heart arteries when it began participating in a three-year clinical trial for the first-of-its-kind drug-eluting Absorb Bioresorbable Vascular Scaffold (BVS).
Childhood cancer survivors living with chronic conditions as adults may experience a kind of accelerated aging due to the late effects of cancer treatment. However, survivors with no chronic conditions enjoy a quality of life similar to that of individuals with no history of cancer, according to a recent study.
- 1 of 2
- next ›